ADVANCED TECHNOLOGY IN BIG DATA AND HEALTH SCIENCES
Apply for R&D project funds
The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) is a project cost-sharing grant program funded by Empire State Development's Division of Science, Technology and Innovation (NYSTAR) program, designed to drive the growth of life and health science businesses in New York State.
By partnering with a UB researcher, life and health sciences companies can gain access to matching funds for collaborative product development and proof-of-concept R&D projects in four main areas.
- Drug Develoment
- Diagnostics
- Medical Devices
- Healthcare IT
Steps to Apply
- Review full RFP watch the overview webinar for for program requirements and details
- Schedule a time to meet with a UB CAT team member below to discuss the program and/or your proposed project. If your project is new to UB CAT, we strongly encourage you to reach out as soon as possible to learn more.
- Submit completed Letter of Intent at the bottom of this page by March 1, 2025. If the project is in alignment with a UB CAT focus area, you will be invited to submit a full project application.
Not ready to submit? Check out our other life sciences resources.
You've got questions. We've got answers!
Learn more at our UB CAT Office Hours
Over the next several weeks, David du Plessis of the UB CAT team will be available for virtual office hours to answer questions about the program and help you determine whether project is the right fit.
David du Plessis
Business Development Manager, Life Sciences
Featured Collaborations
Flag Bio
Norma Nowak, PhD
Looking at systematic activation of the immune system on distribution of mRNA vaccines
Julian Ambrus, MD
Evaluation of novel early markers in Sjögren’s disease
Jun Xia, PhD
Developing sonocrystallization control systems to improve pharmaceutical production
John Kolega, PhD
Development of a blood test to identify dangerous brain aneurysms
Jun Qu, PhD
Developing and assessment of a novel peptide vaccine against Alzheimer's disease
Jonathan Lovell, PhD
Developing and validating novel cancer therapies using immunogenic neopeptides
Swetadri Vasan Setlur Nagesh, PhD
Developing bias reduction algorithms to enhance QAS.AI predictive performance
Pui Man Rosalind Lai, MD
Clinical evaluation of the neuron specific enolase functional activity stroke test (NSE-FAST) in stroke alert patients presenting at UB
David Zlotnick, MD
Robotic clot removal catheters: Simulated use testing with UB physicians for FDA submission